Cancer cachexia, characterized by anorexia, weight loss muscle mass and food intake, which were induced by the and progressive tissue wasting, has been postulated to be tumor presence. Interleukin 6 mRNA in the tumor was also mediated by various cytokines. However, the precise markedly decreased by the transfection of NFB decoy mechanism of cachexia induction is not fully explained. We ODN. It is known that the transcriptional factor E2F plays have developed synthetic double-stranded oligodeoxynua pivotal role in the coordinated transactivation of cell cycle cleotides (ODN) as 'decoy' cis-elements that block the regulatory genes. Therefore, we hypothesized that the binding of nuclear factors to promoter regions of targeted introduction of synthetic double-stranded DNA with high genes, resulting in the inhibition of gene transactivation in affinity for E2F in vivo as 'decoy' cis-elements might inhibit vivo as well as in vitro. This novel molecular strategy could the tumor growth of colon26, resulting in turn in inhibition of be useful for treating a broad range of human diseases cachexia induction. However, injection of E2F decoy ODN including cancer. In this study, we injected decoy ODN tarfailed to inhibit tumor growth and cachexia induction, as geting the transcriptional factor, NF-kappaB (NFB) bindcompared with mismatched decoy ODN. Overall, the ing cis-elements, which are essential for transactivation of present study demonstrated that cachexia induced by gene expression of cytokines, directly into tumors of adenocarcinoma colon26 was inhibited by blocking of adenocarcinoma colon26 in mice, in order to examine NFB, using a novel molecular decoy strategy, without an whether or not cachexia is alleviated by inhibiting the action effect on tumor growth, and also that tumor growth and of cytokines. Tumor growth was not affected by transfeccachexia induction in the colon26 model were not affected tion of NFB decoy ODN as compared with scrambled by E2F decoy ODN. These results suggest that cytokines decoy ODN. Nevertheless, transfection of NFB decoy, but regulated by NFB may play a pivotal role in the induction not scrambled decoy, ODN resulted in attenuation of the of cachexia by colon26, providing a new therapeutic reductions in body weight, epididymal fat, gastrocnemius strategy for cancer cachexia.
Introduction
Cancer cachexia is a common complication of malignancy and is found in more than 60% of patients with malignant disease. 1, 2 Cachexia is characterized by anorexia, anemia, body weight loss and progressive tissue wasting. The effectiveness of cancer therapy is dependent on the presence or absence of cachexia symptoms, because a shorter survival period and lower frequency of response to radiation and chemotherapy are observed in patients with cachexia as compared with patients without weight loss. 1, 3 Although little is known about the precise mechanism of cachexia, recent studies indicate that inappropriate production and release of cytokines such as tumor necrosis factor-␣ (TNF-␣), interleukin-1 (IL-1), interleukin-6 (IL-6) and interferon-␥, which are secreted from both cancer cells and host tissues, are involved in the induction of cachexia. [4] [5] [6] [7] [8] tulated to cause metabolic changes in the host, associated with enhanced energy requirements for tumor growth, resulting in the loss of adipose and muscle tissues. Blockade of the cytokines by their antibodies reversed the body weight loss and tissue wasting without affecting tumor growth. 7 In addition, administration of exogenous recombinant TNF-␣ or IL-6 to healthy animals resulted in the typical cachectic features. 9, 10 Therefore, cytokines play an important role in the pathogenesis of cancer cachexia.
The decoy strategy has recently been developed and is considered a useful tool as a new class of antigene strategy. Transfection of cis-element double-stranded oligodeoxynucleotides (ODN) as decoy has been reported to be a powerful new tool for the study of transcriptional regulation. [11] [12] [13] Transfection of double-stranded ODN corresponding to the cis sequence results in attenuation of the authentic cis-trans interaction, leading to the removal of the trans-factors from the endogenous ciselement, with subsequent modulation of gene expression. Therefore, the decoy approach enables us to treat diseases by modulation of endogenous transcriptional regulation. We have recently revealed that the strategy using transcriptional factors decoy ODN was able to modulate the expression of targeted genes and showed a therapeutic effect in vivo. 14, 15 In this study, we focused on the role of the transcriptional factors, NF-kappaB (NFB) and E2F, in the pathogenesis of cancer cachexia. It has been reported that NFB up-regulates expression of  numerous cytokines including TNF-␣, IL-1, IL-6 and  interleukin-8 (IL-8) , [16] [17] [18] [19] and adhesion molecules such as vascular cell adhesion molecules (VCAM) and intracellular adhesion molecules (ICAM). 20, 21 Therefore, we hypothesize that transfection of NFB decoy ODN may result in the prevention and/or improvement of cancer cachexia, if the expression of cytokines and adhesion molecules involved in the induction of cachexia is inhibited by treatment with NFB decoy ODN. In addition, the transcriptional factor E2F plays a pivotal role in the regulation of cell proliferation. While E2F forms a complex with cyclin A and cdk 2, the major component of the complex during the early part of the cell cycle is the retinoblastoma protein (Rb). [22] [23] [24] As the cells enter S-phase, Rb is phosphorylated and leaves the complex, allowing E2F to induce cell cycle regulatory genes including c-myc, cmyb, cdc2, proliferating cell nuclear antigen (PCNA) and thymidine kinase, [25] [26] [27] [28] [29] resulting in the initiation of cell proliferation. Thus, we also hypothesize that transfection of tumor with sufficient quantities of the decoy ODN containing the E2F binding site would effectively bind E2F, and prevent it from transactivating the expression of cell cycle regulatory genes ( Figure 1 ) and thereby inhibit tumor growth in vivo.
As previously reported, mice bearing the colon26 adenocarcinoma develop a progressive body weight loss and tissue wasting and cytokines play an important role in the induction of cachexia in this tumor model. 7, 30, 31 Therefore, colon26 is a suitable model to determine the role of the transcriptional factors NFB and E2F in the pathogenesis of cancer cachexia. In this study we investigate the effect of NF-B decoy or E2F decoy ODN against colon26-induced cachexia in mice. 
Results
Effect of NFB decoy ODN on colon26-induced cachexia in mice We chose direct injection of decoy ODN into the tumor in order to investigate the effect of decoy ODN in the murine adenocarcinoma colon26 model, because we thought that this injection route for decoy ODN would be most effective at inhibiting local synthesis of cytokines by colon26. Body weight and food intake of tumorbearing mice began to decrease beginning on day 10 after inoculation of colon26 into mice, and the decrease continued until death on day 13, associated with tumor growth (Figure 2 and Table 1 ). When mice were killed on day 13, significant reductions in body mass, epididymal fat, gastrocnemius muscle and carcass were observed in the tumor-bearing mice, accompanied by a severe decrease in food intake ( Figures 2 and 3 and Table 2 ). To enhance the efficiency and stability of decoy ODN further, we employed a Sendai-virus (HVJ)-liposome delivery system which is reported to bypass endocytosis, thereby avoiding degradation in lysosomes. [13] [14] [15] In the preliminary experiments to study the anti-cachectic effect of NFB decoy ODN, we examined the transfection of NFB decoy ODN into the tumor: (1) once a week; or (2) on 3 consecutive days a week, for 2 weeks starting 5 days after tumor inoculation. As a result, prevention of the loss of body weight, epididymal fat, gastrocnemius muscle and carcass was observed, but the difference was not significant (data not shown). Therefore, we decided to employ daily transfection of decoy ODN during tumor growth.
As shown in Figures 2 and 3 and Table 2 , treatment with NFB decoy ODN for 7 consecutive days starting on day 7 resulted in significant prevention of the loss of body weight, epididymal fat, gastrocnemius muscle and carcass. The reduction of food intake was also partially reversed by NFB decoy ODN treatment ( The method was described in the legend of Figure 2 . On the day before food measurement, each group was given about 150 g food. The following day the food remained was weighed and the decrease in weight was divided by the number of mice to determine the food intake per animal. Mice were used in groups of 10. ever, transfection of scrambled decoy ODN did not alter body weight and various organ weights. As shown in Figure 4 , treatment with NFB decoy or scrambled decoy ODN had no influence on the tumor growth in mice. To study the molecular mechanisms of cachexia inhibition by NFB decoy ODN further, we measured IL-6 mRNA in the tumor. IL-6, a potent candidate for cachexia in colon 26 adenocarcinoma model, 30, 31 was decreased in the tumor transfected with NFB decoy ODN as compared with scrambled decoy ODN ( Figure 5 ). IL-6 mRNA in the tumor transfected with scrambled decoy ODN was not different from that in untransfected tumor. Moreover, we transfected FITC-labeled NFB decoy ODN into the tumor, to study the transfection efficiency by the HVJliposome method. As shown in Figure 6 , fluorescence due to FITC-labeled decoy ODN was clearly observed in most cells around the injected sites. In contrast, no fluorescence was observed in untransfected tumor.
Effect of E2F decoy ODN in colon26 model
Next, we focused on the inhibitory effect of transfection of E2F decoy ODN on tumor growth in mice because of the pivotal role played by the transcriptional factor E2F in the regulation of cell proliferation. E2F decoy or mismatched decoy ODN were injected into the colon26 tumor of mice once daily for 7 days starting 7 days after tumor inoculation. However, there was little effect of transfection of E2F decoy ODN on tumor growth in colon26-bearing mice as compared with mismatched decoy ODN ( Table 3 ). The anti-cachectic effect of E2F decoy ODN was also examined in mice bearing colon26 tumor. As shown in Table 3 , transfection of E2F decoy ODN did not cause any changes in body weight and food intake.
Discussion
Synthetic double-stranded ODN as 'decoy' cis-elements block the binding of nuclear factors to promoter regions of targeted genes, resulting in the inhibition of gene transactivation in in vitro assay systems. [11] [12] [13] Recently, a few studies have described application of the 'decoy' ODN strategy as in vivo gene therapy. 14, 15 The present study provides the first evidence of in vivo application of this novel molecular approach as a therapeutic strategy for cancer cachexia. It is well known that the pathophysiological mechanism of cancer is quite complicated. Numerous reports have described the contribution of cytokines and adhesion molecules in the development and/or progression of cancer and/or cachexia. [4] [5] [6] [7] [8] Recent advances in molecular biology provide us with the opportunity to dissect out this complicated disease. Numerous growth factors and cytokines including IL-1, IL-6, IL-8 and TNF-␣, to name a few, regulate this process. However, gene regulation of many cytokines is relatively simple, because the transcriptional factor, NFB, has been reported to up-regulate these cytokines. [16] [17] [18] [19] [20] [21] Therefore, we hypothesize that transfection of NFB decoy ODN results in the abrogation of activation of these cytokines and adhesion molecules in tumor growth, resulting in the prevention and/or regression of cancer. To investigate the feasibility of this strategy, we employed colon26-induced cachexia, 30 since cytokines play a key role in the induction of cachexia in the colon26 tumor system. 7, 31 An important finding of this study was that transfection of NFB decoy ODN resulted in inhibition of cachexia, but not tumor growth, induced by colon26-bearing adenocarcinoma. Colon 26-bearing adenocarcinoma is an experimental model of cachexia that fulfills the criteria of an early effect with a small tumor mass not related to the growth rate of the tumor, and progressive wasting of muscle and fat without a detectable loss of appetite. Several lines of evidence indicate that a pro-inflammatory cytokine, IL-6, plays a major role, albeit partially, in the establishment of cachexia in this model. Inhibition of cachexia by transfection of NFB decoy ODN might be due to the inhibition of local cytokine production, as our results are consistent with previous observations that the source of cytokines, eg IL-6, is colon26 itself, 7, 31 and that expression of IL-6 is regulated by NFB through B-like sequences present in the promoter region of IL-6 gene. 32 Indeed, IL-6 mRNA was decreased in the tumor transfected with NFB decoy ODN as compared with scrambled decoy ODN, as assessed by Northern blotting ( Figure 5 ). Alternatively, it is also possible that inhibition of other NFB-regulated cytokines or adhesion molecules by transfection of NFB decoy ODN is involved in the inhibition of cachexia, since all the cachexia symptoms induced by colon26 could not be fully explained by IL-6 alone. 33, 34 Unfortunately, this study could not fully explain the mechanism by which NFB decoy ODN treatment inhibits the cachexia induced by colon26.
Figure 3 Effect of NFB decoy ODN on the weights of epididymal fat, gastrocnemius muscle and carcass of colon26-bearing mice. NFB decoy ODN or scrambled decoy ODN was injected into the tumor once daily for 7 days. Thirteen days after the tumor inoculation, the epididymal fat, gastrocnemius muscle and carcass (wet and dry) were weighed. Mice were used in groups of 10. Each column represents the mean and s.e. **, P Ͻ 0.01, compared with UT-TB (Dunnett test). UT, untransfected mice; SD, scrambled decoy ODN transfected mice; NF, NFB decoy ODN transfected mice.
Cancer develops in large part as a result of various types of cell proliferation. This process is dependent on the coordinated activation of a series of cell cycle regulatory genes which results in mitosis. A critical element of cell cycle regulation involves the complex formed by E2F, Rb, cyclin A and cdk2. [22] [23] [24] As the cells enter S-phase, Rb is phosphorylated and leaves the complex, allowing E2F to induce cell cycle regulatory genes including c-myc, c-myb, cdc2, PCNA and thymidine kinase, [25] [26] [27] [28] [29] resulting in the initiation of cell proliferation. Accordingly, we hypothesized that transfection of colon26 with a sufficient quantity of decoy ODN containing the E2F cis-element would effectively bind E2F, prevent it from transactivating the gene expression of essential cell cycle regulatory proteins and thereby inhibit tumor growth. Unexpectedly, we failed to show an inhibitory effect of E2F decoy ODN on tumor growth. These results are not consistent with our previous reports that transfection of E2F decoy ODN is effective at inhibiting the proliferation of vascular 
smooth muscle cells and mesangial cells in vivo as well as in vitro.
14, 35 The lack of effect of E2F decoy ODN may be due to a lack of effect on E2F regulation of its target genes (ie poor oligonucleotides, poor uptake, inadequate binding of E2F, etc), or due to a lack of involvement of E2F. However, the former is not likely, since our present study using FITC-labeled ODN revealed wide distribution of transfected decoy ODN (Figure 6 ). In addition, the previous reports mentioned the effective competition of E2F binding by E2F decoy ODN at similar concentrations in vitro, as well as in vivo. 14, 35 Alternatively, a possible explanation for this discrepancy is that the growth regulation of colon26 may be different from that of normal cells and independent of E2F-related mechanisms.
Overall, the present study demonstrates that NFB decoy, but not scrambled decoy, ODN which include synthetic oligodeoxynucleotides with high affinity for the transcription factor NFB, inhibit murine adenocarcinoma colon26-induced cachexia in mice. These results sug- Colon26 was inoculated s.c. to mice and E2F decoy ODN or mismatched decoy ODN was injected to the tumor once daily for 7 days starting 7 days after the tumor inoculation. On day 13 after the tumor inoculation, body weight, tumor growth and food intake were monitored, epididymal fat was weighed. Mice were used in groups of 10. gest that cytokines regulated by NFB are involved in the induction of cachexia by colon26, demonstrating the potential utility of NFB decoy strategy for cancer cachexia as a novel gene therapy. Although NFB decoy ODN failed to inhibit the tumor growth, the inhibition of tumor-associated symptoms such as cachexia might help in the care of patients by improving the quality of life. Moreover, as the intolerance of cancer patients to anticancer drugs due to cachexia is important, NFB decoy ODN could be a potential therapeutic agent against cancer cachexia by inhibiting the local cytokine systems.
Materials and methods

Animals
Male BALB/c mice were purchased from Charles River Japan (Kanagawa, Japan). The mice were kept in conditions of constant temperature and humidity and fed a standard diet and water ad libitum.
Synthesis of oligonucleotides and selection of targeted sequences
The sequences of phosphorothioate double-stranded ODN against NFB and E2F binding sites, scrambled ODN and mismatched ODN used in this study were as previously reported.
14,20
The sequences of the phosphorothioate ODN utilized:
(1) NFB decoy ODN: (consensus sequences are underlined)
5Ј-CCTTGAAGGGATTTCCCTCC-3Ј 3Ј-GGAACTTCCCTAAAGGGAGG-5Ј
Scrambled decoy ODN:
5Ј-TTG CCGTACCTGACTTAGCC-3Ј 3Ј-AACGGCATGGACTGAATCGG-5Ј NFB decoy ODN have been shown to bind the NFB transcription factor. 20 Our previous study demonstrated that NFB decoy ODN inhibited gene expression of IL-1, IL-6, IL-8, ICAM and VCAM in human endothelial cells. 5Ј-CTAGATTTCGAGCG-3Ј 3Ј-TAAAGCTCGCCTAG-5Ј E2F decoy ODN have been shown to bind the E2F transcription factor. 14, 24 Our previous study demonstrated that E2F decoy ODN inhibited gene expression of PCNA, cdc 2 kinase and c-myc in vascular smooth muscle cells.
14 Synthetic ODN were washed with 70% ethanol, dried, and dissolved in sterile Tris-EDTA buffer (10 mm Tris, 1 mm EDTA). The supernatant was purified over NAP 10 column (Pharmacia, Uppsala, Sweden), and quantified by spectrophotometry. ODN were annealed for 2 h while the temperature decreased from 80°C to 25°C.
Preparation of HVJ-liposomes
Phosphatidylserine, phosphatidylcholine and cholesterol were mixed in a weight ratio of 1:4.8:2. [13] [14] [15] The lipid mixture (10 mg) was deposited on the sides of a flask by removal of tetrahydrofuran in a rotary evaporator. Dried lipid was hydrated in 200 l of balanced salt solution (BSS: 137 mm NaCl, 5.4 mm KCl, 10 mm Tris-HCl, pH 7.6) containing decoy ODN. Liposomes were prepared by shaking and sonication. Purified HVJ (Z strain) was inactivated by UV irradiation (110 erg/mm 2 /s) for 3 min just before use. The liposome suspension (0.5 ml, containing 10 mg lipid) was mixed with HVJ (10 000 hemagglutinating units) in a total volume of 4 ml BSS. The mixture was incubated at 4°C for 5 min and then for 30 min with gentle shaking at 37°C. Free HVJ was removed from the HVJ-liposomes by sucrose density gradient centrifugation. The top layer of sucrose gradient was collected for use.
13-15
Evaluation of anti-cachectic effect Colon26 adenocarcinoma was maintained s.c. by 10-day serial passage in BALB/c mice. In the evaluation, a fragment (2 × 2 × 2 mm) of colon26 tumor was implanted s.c. into the left flank of BALB/c mice. One week after tumor inoculation, HVJ-liposome complex containing decoy ODN (50-100 l, 30 m in liposome complex) was injected into the tumor once daily for 7 days. The body and tumor weight, and food intake were monitored three times a week. The tumor weight as derived from caliper measurements of the length and width of the tumors, was calculated as follows:
where a represents the length and b represents the width (mm). On the day before food intake measurement, each animal group was given about 150 g food. The following day the remaining food was weighed and the decrease in weight was divided by the number of mice to determine the food intake per animal.
Thirteen days after tumor inoculation, the epididymal fat and gastrocnemius muscles were removed and their weights were measured. The remaining viscera and the tumors were removed and the carcass wet weight was measured. The carcass was then dried for 3 days in an oven at 80°C and the carcass dry weight was measured.
Northern blot analysis
Transfection of NFB or scrambled decoy ODN was performed as described above. RNA was extracted by RNAzol (Tel-Test, TX, USA), from the tumor transfected with NFB or scrambled decoy ODN at 24 h after transfection by the HVJ-liposome method (30 m within HVJ-liposome complex), for Northern blot analysis. 15 For Northern blot analysis, 20 g of total RNA was subjected to electrophoresis on 1.5% agarose-formaldehyde denaturing gel and transferred to a nitrocellulose membrane (Amersham International, Amersham, UK). The filter was baked, prehybridized and hybridized to IL-6 oligonucleotides or G3PDH (Clontech, Palo Alto, CA, USA) used as probes and labeled by 3Ј end-labeling for Northern blotting. Then the filter was washed and exposed to radiographic film.
Transfection of FITC-labeled decoy ODN FITC-labeled phosphorothioate ODN were provided by Nihon-seihun (Tochigi, Japan). FITC was labeled on the 3Ј and 5Ј ends of NFB decoy ODN. The ODN were lyophilized, resuspended in PBS, and quantified by spectrophotometry. Mice were killed 1 h after transfection and the sections were processed in a standard manner and observed by fluorescence microscopy, after staining in eriochrome black T solution. Elastic fibers stained dark red and were readily distinguishable from the specific FITC-labeled ODN by treatment with eriochrome black T solution. 37, 38 Statistical analysis All values are expressed as mean ± s.e. Analysis of variance was performed and the Dunnett test was used to determine the significance of differences. Values of P Ͻ 0.05 were considered significant.
